|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0030705,
umls-concept:C0033269,
umls-concept:C0034656,
umls-concept:C0038013,
umls-concept:C0332161,
umls-concept:C0392756,
umls-concept:C0666743,
umls-concept:C0680192,
umls-concept:C1274040,
umls-concept:C1517945
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2006-8-28
|
|
pubmed:abstractText |
To examine whether clinical benefits observed after treatment with infliximab were accompanied by improvement in productivity and reduction in time lost from work in a randomized, double-blind, placebo-controlled, multicenter trial of patients with ankylosing spondylitis (AS).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0004-3591
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
55
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
569-74
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16874778-Absenteeism,
pubmed-meshheading:16874778-Adult,
pubmed-meshheading:16874778-Anti-Inflammatory Agents,
pubmed-meshheading:16874778-Antibodies, Monoclonal,
pubmed-meshheading:16874778-Antirheumatic Agents,
pubmed-meshheading:16874778-Attitude to Health,
pubmed-meshheading:16874778-Efficiency,
pubmed-meshheading:16874778-Emotions,
pubmed-meshheading:16874778-Employment,
pubmed-meshheading:16874778-Female,
pubmed-meshheading:16874778-Humans,
pubmed-meshheading:16874778-Male,
pubmed-meshheading:16874778-Middle Aged,
pubmed-meshheading:16874778-Spondylitis, Ankylosing
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Infliximab improves productivity and reduces workday loss in patients with ankylosing spondylitis: results from a randomized, placebo-controlled trial.
|
|
pubmed:affiliation |
University Hospital Maastricht, Maastricht, The Netherlands. dhe@sint.azm.nl
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
